44
Growth Score in past quarter
pts
Heat Score 44 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
295875
Synlico develops a CAR-T cell therapy by combining system biology, single-cell bioinformatics, and synthetic biology.
- Jingwei Lu: Founder & CEO
About the Company
Synlico develops a CAR-T cell therapy by combining system biology, single-cell bioinformatics, and synthetic biology. It also develops an AI-powered drug discovery technology platform based on a computation-centric iterative engineering process to help the healthcare industry study T cells-solid tumors interactions across scales to address the
complexity and heterogeneity of the tumor microenvironment.